COHEN & STEERS, INC.
For the period ended Mar 31, 2025. Filed May 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 2, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Departure of Officer
As reported by the Company on March 10, 2025, Daniel Charles provided notice to the Company of his decision to retire from his positions as Executive Vice President and Head of Global Distribution, after nearly six years of service to the Company and a 37-year career in the asset management industry. In consideration of Mr. Charles’ service to the Company in such positions, on April 30, 2025, the Company entered into a letter agreement with Mr. Charles providing that Mr. Charles’ retirement date will be July 31, 2025 and, subject to certain terms and conditions, upon the retirement date his then-unvested restricted stock units will immediately vest and thereafter continue to be settled pursuant to the terms of the restricted stock unit award agreement applicable to each grant of restricted stock units, including continued compliance with the restrictive covenants contained in such agreements, and he will be eligible for a pro-rated discretionary performance bonus in respect of the 2025 fiscal year.
Rule 10b5-1 and Non-Rule 10b5-1 Trading Arrangements
During the three months ended March 31, 2025, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act)adopted, terminated, or modified a Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 1933, as amended).
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.